Case-control study of risk factors for the development of enterococcal bacteremia

被引:14
|
作者
Caballero-Granado F.J. [1 ]
Becerril B. [2 ]
Cisneros J.M. [1 ]
Cuberos L. [2 ]
Moreno I. [1 ]
Pachón J. [1 ]
机构
[1] Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen del Rocío, 41013 Seville, Avenida Manuel Siurot s/n
[2] Servicio de Microbiología, Hospital Universitario Virgen del Rocío, 41013 Seville, Avenida Manuel Siurot s/n
关键词
Catheter; Intensive Care Unit; Multivariate Analysis; Neutropenia; Cephalosporin;
D O I
10.1007/s100960000429
中图分类号
学科分类号
摘要
To determine the risk factors involved in the development of enterococcal bacteremia, a prospective, observational, case-control study was carried out over 18 months. All episodes of enterococcal bacteremia with clinical significance detected in adults were included. A control matched by sex, age and hospitalization ward (medical, surgical or intensive care unit) was selected randomly for each patient with enterococcal bacteremia. Uni- and multivariate analyses of the epidemiological characteristics of both groups were performed. Etiologic fractions of every risk factor were also determined. One hundred twenty-two pairs were included. The severity of the chronic underlying diseases was similar in both groups. Neutropenia, cirrhosis, organ transplantation, intravascular catheter, urinary catheter, nasogastric tube, parenteral nutrition and previous administration of cephalosporins and imipenem were the factors associated with enterococcal bacteremia in the univariate analysis. The factors independently associated with enterococcal bacteremia in the multivariate analysis were neutropenia (odds ratio [OR]=8), urinary catheter (OR=3) and previous administration of cephalosporins (OR=4) and imipenem (OR=10). Their respective etiologic fractions were 9%, 44%, 11% and 29%. Efforts to reduce the occurrence of enterococcal bacteremia should be focused on appropriate use of cephalosporins, imipenem and external devices.
引用
收藏
页码:83 / 90
页数:7
相关论文
共 50 条
  • [1] Case-control study of risk factors for the development of enterococcal bacteremia
    Caballero-Granado, FJ
    Becerril, B
    Cisneros, JM
    Cuberos, L
    Moreno, I
    Pachón, J
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (02) : 83 - 90
  • [2] Risk factors for infective endocarditis in patients with enterococcal bacteremia: A case-control study
    Anderson, DJ
    Murdoch, DR
    Sexton, DJ
    Reller, LB
    Stout, JE
    Cabell, CH
    Corey, GR
    [J]. INFECTION, 2004, 32 (02) : 72 - 77
  • [3] Risk Factors for Infective Endocarditis in Patients with Enterococcal Bacteremia: A Case-Control Study
    D. J. Anderson
    D. R. Murdoch
    D. J. Sexton
    L. B. Reller
    J. E. Stout
    C. H. Cabell
    G. R. Corey
    [J]. Infection, 2004, 32 : 72 - 77
  • [4] RISK-FACTORS IN NOSOCOMIAL BACTEREMIA - CASE-CONTROL STUDY
    SPENGLER, RF
    GREENOUGH, WB
    STOLLEY, PD
    [J]. CLINICAL RESEARCH, 1977, 25 (03): : A331 - A331
  • [5] A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia
    Bhavnani, SM
    Drake, JA
    Forrest, A
    Deinhart, JA
    Jones, RN
    Biedenbach, DJ
    Ballow, CH
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (03) : 145 - 158
  • [6] Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers A retrospective case control study
    Kaya, Abdurrahman
    Kaya, Sibel Yildiz
    Balkan, Ilker Inanc
    Bayramlar, Osman Faruk
    Mete, Bilgul
    Saltoglu, Nese
    Aygun, Gokhan
    Tabak, Omer Fehmi
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (9-10) : 478 - 483
  • [7] Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizersA retrospective case control study
    Abdurrahman Kaya
    Sibel Yıldız Kaya
    Ilker Inanç Balkan
    Osman Faruk Bayramlar
    Bilgül Mete
    Neşe Saltoglu
    Gökhan Aygün
    Ömer Fehmi Tabak
    [J]. Wiener klinische Wochenschrift, 2021, 133 : 478 - 483
  • [8] Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients:: A case-control study
    Apisarnthanarak, A
    Mayfield, JL
    Garison, T
    McLendon, PM
    DiPersio, JF
    Fraser, VJ
    Polish, LB
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (04): : 269 - 274
  • [9] Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study
    Sumida, Kosuke
    Chong, Yong
    Miyake, Noriko
    Akahoshi, Tomohiko
    Yasuda, Mitsuhiro
    Shimono, Nobuyuki
    Shimoda, Shinji
    Maehara, Yoshihiko
    Akashi, Koichi
    [J]. PLOS ONE, 2015, 10 (07):
  • [10] Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study
    Ko, Jae-Hoon
    Kang, Cheol-In
    Lee, Woo Joo
    Huh, Kyungmin
    Yoo, Jeong Rae
    Kim, Kwangmin
    Cho, Sun Young
    Ha, Young Eun
    Chung, Doo Ryeon
    Lee, Nam Yong
    Peck, Kyong Ran
    Song, Jae-Hoon
    [J]. SUPPORTIVE CARE IN CANCER, 2015, 23 (02) : 377 - 384